Medtronic is a global medical technology company that develops and sells implantable devices, surgical tools, and monitoring systems to treat chronic and acute conditions. The company operates through three primary portfolios: Cardiovascular, Neuroscience, and Medical Surgical. The Cardiovascular segment provides devices for heart rhythm disorders and heart valve disease, while the Neuroscience segment focuses on spine surgery and brain stimulation. The Medical Surgical segment includes robotic surgery systems and patient monitoring equipment. Medtronic uses a capital-plus-consumable business model, selling equipment like mapping systems and robotic consoles to build an installed base. This base drives recurring sales of higher-margin consumables, including catheters, leads, and spinal implants. The company sells primarily through a direct sales force that manages relationships with specialized physicians in over 150 countries. Medtronic is currently separating its diabetes business to focus on its core portfolios. Its growth strategy focuses on expanding its presence in cardiac ablation, renal denervation for hypertension, and surgical robotics. Medtronic also uses tuck-in M&A and venture investments to grow its product pipeline and acquire new technologies.